Bausch + Lomb Corporation (BLCO)

NYSE

$21.51

$+0.01

(+0.05%)

Pre-Market

Bausch + Lomb Corporation (BLCO) Live Price Chart

Last updated: ⁦2026-11-11 13:05:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bausch + Lomb Corporation (BLCO) operates in the OPHTHALMIC GOODS sector and is listed on NYSE. The stock is currently priced at $21.51, with a market capitalization of $7.49B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.44 to $21.51. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7.49B
Open	$21.51
Day's High	$21.95
Day's Low	$10.45
Previous Close	$21.37
Volume	837.00
Average Volume	632.69K
P/E Ratio	--
52-Week High	$21.51
52-Week Low	$14.44
Dividend Yield	--
Earnings Date	--

Bausch + Lomb Corporation (BLCO) Pre-Market Stock Price

Bausch + Lomb Corporation (BLCO) is trading at $21.51 in pre-market trading as of 2026-11-11 12:56:00, up 0.63% ($0.13) from the previous close of $21.37

Pre-market trading shows how investors are pricing BLCO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Bausch + Lomb Corporation (BLCO) 7-Day Stock Price Change

Over the past seven days, Bausch + Lomb Corporation (BLCO) moved from $20.01 to $21.51, representing a gain of 7.47% ($1.49).

The stock traded between $19.52 and $21.51 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 974.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BLCO 52-Week Price Position

Position in Range: 100.0%

52W Low$14.44

52W High$21.51

BLCO is currently trading at $21.51, placing it 100.0% of the way from its 52-week low of $14.44 to its 52-week high of $21.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bausch + Lomb Corporation (BLCO)?

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.

Bausch + Lomb Corporation Information

Industry	OPHTHALMIC GOODS
Employees	13000
Exchange	NYSE
Company Website	https://www.bausch.com

How to Buy Bausch + Lomb Corporation (BLCO) Stock on MEXC

Eligible investors can buy real shares of Bausch + Lomb Corporation (BLCO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BLCO and Place Your Order

Open the RealStocks trading page and search for BLCO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bausch + Lomb Corporation (BLCO) stock price today?

Bausch + Lomb Corporation (BLCO) is currently trading at $ 21.51, up 0.63% ($0.13) from the previous close of $ 21.37. Intraday prices update in real time during regular trading hours.

2.Is BLCO stock going up or down today?

As of 2026-11-11 12:56:00, BLCO is trading at $ 21.51, up 0.63% ($0.13) from its previous close of $ 21.37. The stock has traded between $ 10.45 and $ 21.95 during today’s regular session. Past price movements do not guarantee future results.

3.What is BLCO pre-market price?

As of 2026-11-11 12:56:00, BLCO is trading at $ 21.51 in pre-market trading, up 0.63% ($0.13) from the previous close of $ 21.37. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BLCO after-hours price?

As of 2026-11-11 12:56:00, BLCO is trading at $ 21.51 in after-hours trading, up 0.63% ($0.13) from the regular-session close of $ 21.37. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BLCO stock trading now?

BLCO trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BLCO sit relative to its 52-week high and low?

Over the past 52 weeks, BLCO has traded between a low of $ 14.44 and a high of $ 21.51. At $ 21.51, the stock is positioned 100.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bausch + Lomb Corporation in?

Bausch + Lomb Corporation (BLCO) operates in the OPHTHALMIC GOODS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bausch + Lomb Corporation's market capitalization and where is it listed?

Bausch + Lomb Corporation is listed on the NYSE exchange with a market capitalization of $ 7.49B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BLCO valued in terms of P/E ratio and EPS?

BLCO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.31. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bausch + Lomb Corporation pay a dividend?

Bausch + Lomb Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.